Ingalls & Snyder LLC Novavax Inc Call Options Transaction History

Ingalls & Snyder LLC

5 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 11, 2022	BUY	$36.28 - $75.29 $145,120 - $301,160	4,000 Added 114.29%	7,500 $438,000
Q1 2022 May 09, 2022	SELL	$69.73 - $142.9 $55,784 - $114,320	-800 Reduced 18.6%	3,500 $1.12 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $26,912 - $43,594	200 Added 4.88%	4,300 $1.38 Million
Q3 2021 Oct 27, 2021	BUY	$177.8 - $270.58 $17,780 - $27,058	100 Added 2.5%	4,100 $1.31 Million
Q2 2021 Aug 03, 2021	BUY	$121.0 - $257.67 $484,000 - $1.03 Million	4,000 New	4,000 $1.28 Million

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ingalls & Snyder LLC, based on Form 13F filings with the SEC.

Stay updated on Ingalls & Snyder LLC with notifications on news.